CORRESP Filing
Matinas BioPharma Holdings, Inc.
Date: April 28, 2025 · CIK: 0001582554 · Accession: 0001641172-25-006376
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286686
Letter
Matinas BioPharma Holdings, Inc.
1545 Route 206 South, Suite 302
Bedminster, New Jersey 07921
April 28, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Matinas BioPharma Holdings, Inc. Registration Statement on Form S-3 (File No. 333-286686)
Filed on April 22, 2025
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Matinas BioPharma Holdings, Inc. hereby requests that the above-referenced Registration Statement (the " Registration Statement ") be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on April 29, 2025, or as soon as practicable thereafter.
Please call Tracy Buffer of Lowenstein Sandler LLP at (973) 597-2434 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours,
MATINAS BIOPHARMA HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm Matinas BioPharma Holdings, Inc. 1545 Route 206 South, Suite 302 Bedminster, New Jersey 07921 April 28, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Matinas BioPharma Holdings, Inc. Registration Statement on Form S-3 (File No. 333-286686) Filed on April 22, 2025 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, Matinas BioPharma Holdings, Inc. hereby requests that the above-referenced Registration Statement (the " Registration Statement ") be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on April 29, 2025, or as soon as practicable thereafter. Please call Tracy Buffer of Lowenstein Sandler LLP at (973) 597-2434 to confirm the effectiveness of the Registration Statement or with any questions. Very truly yours, MATINAS BIOPHARMA HOLDINGS, INC. By: /s/ Jerome D. Jabbour Name: Jerome D. Jabbour Title: Chief Executive Officer